Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. CorMedix Inc shares valued at $131,300 were sold by DUNTON ALAN W on Sep 12 ’25. At $13.13 per share, DUNTON ALAN W sold 10,000 shares. The insider’s holdings dropped to 40,250 shares worth approximately $0.45 million following the completion of this transaction.
Also, Todisco Joseph sold 50,000 shares, netting a total of over 650,000 in proceeds. Following the sale of shares at $13.00 each, the insider now holds 509,496 shares.
Before that, DUNTON ALAN W had added 10,000 shares to its account. In a trade valued at $130,950, the Director bought CorMedix Inc shares for $13.10 each.
As published in their initiating research note from H.C. Wainwright on June 30, 2025, CorMedix Inc [CRMD] has been a Buy and the price target has been revised to $20. Analysts at D. Boral Capital downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late June. As of March 07, 2025, Leerink Partners has initiated its “an Outperform” rating for CRMD. Earlier on January 13, 2025, D. Boral Capital initiated its rating. Their recommendation was “a Buy” for CRMD stock.
Analyzing CRMD Stock Performance
On last trading session, CorMedix Inc [NASDAQ: CRMD] plunged -4.06% to $11.12. The stock’s lowest price that day was $11.085, but it reached a high of $11.745 in the same session. During the last five days, there has been a drop of approximately -13.06%. Over the course of the year, CorMedix Inc shares have jumped approximately 60.00%.
Is CorMedix Inc subject to short interest?
Stocks of CorMedix Inc saw a sharp rise in short interest on 2025-08-29 jumping by 1.21 million shares to 11.89 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 10.68 million shares. A jump of 10.15% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.56 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.56.
Which companies own the most shares of CorMedix Inc (CRMD)?
In terms of CorMedix Inc share price expectations, FactSet research, analysts set an average price target of 17 in the next 12 months, up nearly 46.68% from the previous closing price of $11.59. Analysts anticipate CorMedix Inc stock to reach 17 by 2025, with the lowest price target being 17. In spite of this, 2 analysts ranked CorMedix Inc stock as Buy at the end of 2025. On August 26, 2024, Rodman & Renshaw assigned a price target of “a Buy” to the stock and initiated coverage with a $13.
